Abstract:Lyme disease, caused by Borrelia burgdorferi, is the most common tick-borne illness and an important emerging zoonosis in the United States and Europe. While most patients with Lyme disease can be cured with a 2-4 week antibiotic therapy with doxycycline, amoxicillin or cefuroxime, about 10%-20% patients continue to suffer persistent symptoms of fatigue, pain or joint and muscle aches, and neurocognitive manifestations that last 6 months or more despite the treatment, a condition called post-treatment Lyme disease syndrome (PTLDS). The cause for PTLDS is unclear but one possibility is persistent infection with B. burgdorferi. One intriguing feature of B. burgdorferi is its ability to develop variant forms such as round bodies and aggregated biofilm-like microcolonies as a log phase culture consisting primarily of spirochete forms grows older or under stress conditions. Here we isolated biofilm-like microcolony and planktopic form (spirochetal forms and ruond body) from stationary phase culture and compared the drug susceptibility of these different forms. We found that the stationary phase planktonic (SP) form and microcolony (MC) form of B. burgdorferi were much more tolerant to the current clinically used antibiotics, doxycycline, ceftriaxone and cefuroxime than log phase (LOG) spirochetal form. In addition, we also compared the ability of the variant forms to cause disease in a mouse arthritis model. Surprisingly, the SP form and particularly the MC form caused a more severe arthritis with an earlier onset of inflammation and joint swelling than the log phase spirochetal form. MC-infected mice showed significant joint swelling as early as 9 days post-infection, while the LOG form and SP form did not cause significant swelling. At 21 days, the joint swelling of the MC group dramatically increased and peaked; but the SP form showed significant swelling at this time but less severe than the MC infected group. The LOG infected mice were just beginning to develop joint swelling at Day 21 post-infection, with only slight swelling. At 30-day post infection, the SP group mice were also found to develop similar severity of joint swelling as the MC group, but the log phase group still did not show significant swelling. However, at 35-day post infection, all three infected groups showed similar degree of significant joint swelling. After 35-day infection, the joint swelling of the three infected groups relapsed during the 90-day observation. Thus, we developed a visual Lyme arthritis model using biofilm inocula that can be used for more efficient evaluation of treatment regimens for persistent B. burgdorferi infections. Our findings provide new insight about disease pathogenesis and may have implications for understanding PTLDS and recalcitrance of treatment with current Lyme antibiotics in PTLDS patients, due to possible biofilm inoculation during tick-bite.

Evidence for the Presence of Borrelia burgdorferi Biofilm in Infected Mouse Heart Tissues

Biofilm Structures of Borrelia burgdorferi Not Only Display More Tolerance to Lyme Antibiotics But Also Cause More Severe Pathology In a Mouse Arthritis Model: Implications for Understanding Persistence, PTLDS and Treatment

Visualization of the Dynamics of Invasion and Intravasation of the Bacterium That Causes Lyme Disease in a Tissue Engineered Dermal Microvessel Model

Borrelia burgdorferi adhere to blood vessels in the dura mater and are associated with increased meningeal T cells during murine disseminated borreliosis

Role of the Surface Lipoprotein BBA07 in the Enzootic Cycle of Borrelia Burgdorferi.

Characterization of the Highly Regulated Antigen BBA05 in the Enzootic Cycle of Borrelia Burgdorferi

Mouse Models for the Study of Borrelia burgdorferi Infection

Comparative reservoir competence of Peromyscus leucopus, C57BL/6J, and C3H/HeN for Borrelia burgdorferi B31

Animal Models of Lyme Carditis. Understanding How to Study a Complex Disease

Impact of E. muris infection on B. burgdorferi- induced joint pathology in mice

Interaction of primary mast cells with Borrelia burgdorferi (sensu stricto): role in transmission and dissemination in C57BL/6 mice

Stationary Phase Persister/biofilm Microcolony of Borrelia Burgdorferi Causes More Severe Disease in a Mouse Model of Lyme Arthritis: Implications for Understanding Persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and Treatment Failure.

Secretory leukocyte protease inhibitor influences periarticular joint inflammation in B. burgdorferi-infected mice

Rapid clearance of Borrelia burgdorferi from the blood circulation

Molecular Interactions That Enable Movement of the Lyme Disease Agent from the Tick Gut into the Hemolymph

Novel Microbial Virulence Factor Triggers Murine Lyme Arthritis.

Cellular and transcriptome signatures unveiled by single-cell RNA-Seq following ex vivo infection of murine splenocytes with Borrelia burgdorferi

Comparative reservoir competence of , C57BL/6J, and C3H/HeN for B31

Male C57BL/6J mice have higher presence and abundance of Borrelia burgdorferi in their ventral skin compared to female mice

Borrelia burgdorferi Manipulates Innate and Adaptive Immunity to Establish Persistence in Rodent Reservoir Hosts

Concurrent Infection of the Human Brain with Multiple Borrelia Species